A detailed history of Franklin Resources Inc transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 98,652 shares of LYEL stock, worth $153,897. This represents 0.0% of its overall portfolio holdings.

Number of Shares
98,652
Previous 83,215 18.55%
Holding current value
$153,897
Previous $185,000 22.7%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.3 - $3.01 $20,068 - $46,465
15,437 Added 18.55%
98,652 $143,000
Q2 2023

Aug 11, 2023

BUY
$1.89 - $3.86 $157,276 - $321,209
83,215 New
83,215 $264,000

Others Institutions Holding LYEL

About Lyell Immunopharma, Inc.


  • Ticker LYEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 247,824,992
  • Market Cap $387M
  • Description
  • Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...
More about LYEL
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.